Navigation Links
Heritage Pharmaceuticals Inc. Signs Exclusive Development Supply & Distribution Agreement with Dexcel Ltd.
Date:8/5/2014

EATONTOWN, N.J., Aug. 5, 2014 /PRNewswire/ -- Heritage Pharmaceuticals Inc. ("Heritage") has signed an Exclusive Development, Supply & Distribution Agreement with Dexcel Ltd. ("Dexcel") for an Extended Release ANDA drug product. Dexcel will be responsible for the development, registration and manufacturing of the product, and Heritage Pharmaceuticals will be responsible for marketing and distribution in the U.S. The product generates generic annual U.S. sales of approximately $60 million, per IMS Health. Financial terms of the agreement were not disclosed.

Jeffrey A. Glazer, Heritage's Vice Chairman and CEO stated, "I am pleased to expand our relationship with Dexcel for high barrier, technology driven pharmaceutical products. This agreement builds upon our platform of pipeline expansion through strategic alliance and will complement our organic product assets as we continue to offer a broad portfolio of value driven medicine to the U.S. consumer."

About Heritage

Heritage Pharmaceuticals Inc. is a specialty pharmaceutical company engaged in the development, manufacturing, sales and marketing of generic and legacy branded pharmaceutical products for the U.S. prescription drug market. Since inception, our customers have experienced the benefits of our continuous product expansion and global alliance network that has produced an impressive portfolio of over 150 products spanning multiple dosage forms. Heritage's products cover a number of therapeutic categories, including but not limited to: oncology, cardiovascular, metabolic disease, anti-infective and pain management. Whether its oral solids or complex injectables, the Heritage portfolio is poised to continue to rapidly expand and deliver the Value Driven Medicine required to keep our customers competitive in the marketplace.

About Dexcel Pharma

Dexcel Pharma is a private international specialty pharmaceutical group, de
'/>"/>

SOURCE Heritage Pharmaceuticals Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Heritage Provider Network, UCLA and Open mHealth announce the launch of $100,000 mobile apps health prize challenge
2. Heritage-DREAM, National Cancer Institute Breast Cancer Network Inference Prize Announced
3. George Rosenkranz to Receive 2013 Biotechnology Heritage Award
4. Heritage Pharma Announces The Return Of Tetracycline HCI Capsules
5. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
6. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
7. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
8. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
9. Icahn Issues Statement Regarding Amylin Pharmaceuticals
10. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
11. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... 27, 2015 Harwood Feffer LLP ( www.hfesq.com ... directors of Aerie Pharmaceuticals, Inc. ("Aerie" or the "Company") ... breached its fiduciary duties to shareholders. On ... announcing results from its first Phase 3 registration trial ... that in the trial, Rhopressa failed to meet its ...
(Date:4/27/2015)... 2015  Eiger BioPharmaceuticals, Incorporated today announced the presentation ... in patients with chronic hepatitis delta viral (HDV) infection. ... at Ankara University Medical School, Turkey ... LOWR HDV - 1 (LOnafarnib With and ... randomized subjects to receive different doses of lonafarnib with ...
(Date:4/27/2015)... N.J. , April 27, 2015  CytoSorbents ... critical care immunotherapy commercializing its CytoSorb® extracorporeal cytokine ... announced the appointment of Dr. Joerg Scheier ... Dr. Scheier is a specialist in intensive ... years of combined experience in treating critically-ill patients ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Aerie Pharmaceuticals, Inc. 2Eiger Bio Announces Interim Results of Lonafarnib in Combination with Ritonavir or Pegylated Interferon in Patients Infected with Hepatitis Delta Virus (HDV) 2Eiger Bio Announces Interim Results of Lonafarnib in Combination with Ritonavir or Pegylated Interferon in Patients Infected with Hepatitis Delta Virus (HDV) 3CytoSorbents Appoints Dr. Joerg Scheier as European Medical Director 2CytoSorbents Appoints Dr. Joerg Scheier as European Medical Director 3CytoSorbents Appoints Dr. Joerg Scheier as European Medical Director 4CytoSorbents Appoints Dr. Joerg Scheier as European Medical Director 5
(Date:4/27/2015)... Humble, TX (PRWEB) April 27, 2015 Sitting ... legs to ache and feel tired, and for those whose ... such as receptionists and taxi cab drivers, or to be ... teachers and hairdressers, the discomfort can be more severe and ... tired, achy leg syndrome. Dr. Madaiah Revana of Northeast Houston ...
(Date:4/27/2015)... Douglas Fitzpatrick not only sells auto, life ... also helps secure homes for animals. On May 9, 2015 ... a booth at the 2015 Fetch A Friend Adopt-a-thon at ... Columbus, Ohio. , “I am very excited to be ... adoptable pets from more than forty different rescues, shelters and ...
(Date:4/27/2015)... Ticket Down is a reputable source ... Valley Music Theatre and the Isleta Amphitheater. ... Mexico area can celebrate because their favorite performer will ... Buffett will be performing alongside legendary performers, Huey Lewis ... during the summer and fall months of 2015 are ...
(Date:4/27/2015)... April 27, 2015 The global ... a lower CAGR in developed countries; however, it ... countries such as China, India and Brazil in ... analyzers market is driven by factors such as ... laboratories, development of high-throughput hemostasis analyzers, developments in ...
(Date:4/27/2015)... Volpara Solutions today announced the ... Society of Breast Imaging’s SBI/ACR Breast Imaging Symposium ... #214). VolparaDensity, the first breast density assessment ... tomosynthesis datasets from multiple manufacturers, is already in ... worldwide. , The latest version of ...
Breaking Medicine News(10 mins):Health News:Northeast Houston Vein Center Offers Tips on How to Treat Achy Legs 2Health News:Northeast Houston Vein Center Offers Tips on How to Treat Achy Legs 3Health News:Farmers Insurance Agent Douglas Fitzpatrick Ensures Pets Find Homes 2Health News:Cheap Jimmy Buffett Tickets at Alpine Valley Music Theatre in Elkhorn, WI and at Isleta Amphitheater in Albuquerque, NM Now on Sale at TicketDown.com 2Health News:Coagulation Analyzers Market Concluded to Reach $3.58 billion by 2019 2Health News:Coagulation Analyzers Market Concluded to Reach $3.58 billion by 2019 3Health News:Volpara Solutions Releases VolparaDensity 3.1 for Use with Tomosynthesis Systems from Multiple Manufacturers at SBI 2Health News:Volpara Solutions Releases VolparaDensity 3.1 for Use with Tomosynthesis Systems from Multiple Manufacturers at SBI 3
... ... referrals using a proprietary system that automatically matches the right clients with the right ... the lenders while increasing conversions for retailers. , ... Orlando, FL (PRWEB) June 17, 2009 -- The world ...
... Epeius Biotechnologies ( www.epeiusbiotech.com ) announced ... Fast Track designation by the U.S. Food and Drug ... advanced or metastatic pancreatic cancer. The FDA Fast Track ... to facilitate the development and expedite the review of ...
... 17 STAAR Surgical Company (Nasdaq: STAA ), ... ophthalmic products, today announced the completion of a registered direct ... price of $1.88 per share, which was the closing market ... be approximately $8.0 million because the Company did not use ...
... ... Energy Medicine) announces that it is taking sign-ups for this year,s annual subtle energies ... July 1st and is called "Sacred Synthesis: Science with Heart". , ... Denver, CO (PRWEB) June 17, 2009 ...
... ... 4 of Remote Control 4.0. It allows help desk staff to administer and ... makes it easy to find computers With its unique search engine. It can ... obtained from http://www.intelliadmin.com/blog/index.php/2009/06/remote-control-40-beta-rc4-and-usb-disabler-pro/ , ...
... , ... of the Dermatology Center of Plano will be relocating his practice to a brand new state ... new practice under the name, Center for Dermatology and Cosmetic Laser Surgery. , ... (PRWEB) June 17, 2009 -- Dr. Bryan Selkin, the ...
Cached Medicine News:Health News:The Equipment Leasing/Financing World Now Has its First Exclusive Online Referral Service 2Health News:The Equipment Leasing/Financing World Now Has its First Exclusive Online Referral Service 3Health News:Epeius Biotechnologies' Rexin-G Receives FDA Fast Track Designation for the Treatment of Pancreatic Cancer 2Health News:Epeius Biotechnologies' Rexin-G Receives FDA Fast Track Designation for the Treatment of Pancreatic Cancer 3Health News:STAAR Surgical Completes Common Stock Offering 2Health News:STAAR Surgical Completes Common Stock Offering 3Health News:2009 ISSSEEM Conference to Have Deepak Chopra Discuss Bridging Science and Spirit 2Health News:2009 ISSSEEM Conference to Have Deepak Chopra Discuss Bridging Science and Spirit 3Health News:Windows 7 Compatible Remote Desktop Software Released (Beta 4) 2Health News:New State of the Art Dermatology Center in Plano TX 2
This new dedicated VICTOR2 model is for fluorescence and luminescence measurements....
... VICTOR2 V measures ... polarization, luminescence, time-resolved ... absorbance. A red-sensitive ... assay. All technologies ...
... is the modular VICTOR2 ... high density TR-fluorometry, stacker ... The extra high density ... excitation beam for TRF ...
Flexible and sensitive fluorescence/luminescence microplate reader for endpoint and kinetic...
Medicine Products: